• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性荧光非肽类血管加压素 V₂ GPCR 拮抗剂:在配体筛选和寡聚化测定中的应用。

Selective fluorescent nonpeptidic antagonists for vasopressin V₂ GPCR: application to ligand screening and oligomerization assays.

机构信息

Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS/Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67412 Illkirch, France.

出版信息

J Med Chem. 2012 Oct 25;55(20):8588-602. doi: 10.1021/jm3006146. Epub 2012 Oct 5.

DOI:10.1021/jm3006146
PMID:22984902
Abstract

A series of fluorescent benzazepine ligands for the arginine-vasopressin V₂ receptor (AVP V₂R) was synthesized using "Click" chemistry. Their in vitro pharmacological profile at AVP V₂R, V(1a)R, V(1b)R, and oxytocin receptor was measured by binding assay and functional studies. Compound 9p, labeled with Lissamine Rhodamine B using novel solid-phase organic tagging (SPOrT) resin, exhibited a high affinity for V₂R (4.0 nM), an excellent selectivity toward V₂R and antagonist properties. By changing the nature of the dye, DY647 and Lumi4-Tb probes 44 and 47 still display a high affinity for V₂R (5.6 and 5.8 nM, respectively). These antagonists constitute the first high-affinity selective nonpeptidic fluorescent ligands for V₂R. They enabled the development of V₂R time-resolved FRET-based assay readily amenable to high-throughput screening. Taking advantage of their selectivity, these compounds were also successfully involved in the study of V(1a)R-V₂R dimerization on cell surface.

摘要

使用“点击”化学合成了一系列用于精氨酸加压素 V₂ 受体(AVP V₂R)的荧光苯并氮杂䓬配体。通过结合测定和功能研究,测量了它们在 AVP V₂R、V(1a)R、V(1b)R 和催产素受体上的体外药理学特性。用新型固相有机标记(SPOrT)树脂标记的 Lissamine Rhodamine B 的化合物 9p 对 V₂R 具有高亲和力(4.0 nM),对 V₂R 具有优异的选择性和拮抗剂特性。通过改变染料的性质,DY647 和 Lumi4-Tb 探针 44 和 47 仍然对 V₂R 具有高亲和力(分别为 5.6 和 5.8 nM)。这些拮抗剂构成了第一个高亲和力的选择性非肽荧光 V₂R 配体。它们使基于 V₂R 时间分辨荧光共振能量转移的测定法的开发变得容易适用于高通量筛选。利用它们的选择性,这些化合物还成功地参与了细胞表面上 V(1a)R-V₂R 二聚化的研究。

相似文献

1
Selective fluorescent nonpeptidic antagonists for vasopressin V₂ GPCR: application to ligand screening and oligomerization assays.选择性荧光非肽类血管加压素 V₂ GPCR 拮抗剂:在配体筛选和寡聚化测定中的应用。
J Med Chem. 2012 Oct 25;55(20):8588-602. doi: 10.1021/jm3006146. Epub 2012 Oct 5.
2
Selective nonpeptidic fluorescent ligands for oxytocin receptor: design, synthesis, and application to time-resolved FRET binding assay.用于催产素受体的选择性非肽荧光配体:设计、合成及其在时间分辨荧光共振能量转移结合测定中的应用。
J Med Chem. 2015 Mar 12;58(5):2547-52. doi: 10.1021/jm501395b. Epub 2015 Feb 12.
3
Solid-phase organic tagging resins for labeling biomolecules by 1,3-dipolar cycloaddition: application to the synthesis of a fluorescent non-peptidic vasopressin receptor ligand.用于通过1,3-偶极环加成标记生物分子的固相有机标记树脂:在荧光非肽类血管加压素受体配体合成中的应用。
Chemistry. 2008;14(20):6247-54. doi: 10.1002/chem.200800273.
4
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.血管加压素和催产素V1a、V1b、V2及OT受体的肽类和非肽类激动剂与拮抗剂:研究工具及潜在治疗药物
Prog Brain Res. 2008;170:473-512. doi: 10.1016/S0079-6123(08)00437-8.
5
Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.非肽类血管加压素V1A受体选择性拮抗剂YM218对人血管加压素和催产素受体的作用。
Pharmacol Res. 2005 Mar;51(3):275-81. doi: 10.1016/j.phrs.2004.09.006.
6
Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.基于新型荧光血管加压素和催产素受体配体的开发,通过均相分析实现高效药物筛选。
J Med Chem. 2007 Oct 4;50(20):4976-85. doi: 10.1021/jm061404q. Epub 2007 Sep 12.
7
Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.基于对[脱氨基-半胱氨酸1]精氨酸加压素4位的修饰设计人血管加压素V1b受体的强效和选择性激动剂。
J Med Chem. 2004 Apr 22;47(9):2375-88. doi: 10.1021/jm030611c.
8
The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigations.发现用于药理学、功能和结构研究的新型血管加压素V1b受体配体。
J Neuroendocrinol. 2004 Apr;16(4):356-61. doi: 10.1111/j.0953-8194.2004.01163.x.
9
Conformational aspects of differences in requirements for oxytocin and vasopressin receptors.催产素和加压素受体需求差异的构象方面
J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):703-13. doi: 10.3109/10799899509045250.
10
In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245).在体外和体内对强效和选择性血管加压素 V(1A)受体拮抗剂 4-[4-(4-氯苯基)-5-[1,2,3]三唑-2-基甲基-4H-[1,2,4]三唑-3-基]-哌啶-1-基-(3,5-二氟苯基)甲酮 (PF-00738245) 的药理学特性进行研究。
Eur J Pharmacol. 2011 Nov 30;670(2-3):347-55. doi: 10.1016/j.ejphar.2011.09.034. Epub 2011 Sep 21.

引用本文的文献

1
Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin.血管加压素V2受体的非活性结构揭示了托伐普坦和曼巴夸雷汀毒素的不同结合模式。
Nat Commun. 2025 Apr 24;16(1):3899. doi: 10.1038/s41467-025-59114-5.
2
Biased activation of the vasopressin V2 receptor probed by molecular dynamics simulations, NMR and pharmacological studies.通过分子动力学模拟、核磁共振和药理学研究探究血管加压素V2受体的偏向性激活
Comput Struct Biotechnol J. 2024 Oct 24;23:3784-3799. doi: 10.1016/j.csbj.2024.10.039. eCollection 2024 Dec.
3
Structure of the vasopressin hormone-V2 receptor-β-arrestin1 ternary complex.
抗利尿激素-V2受体-β-抑制蛋白1三元复合物的结构
Sci Adv. 2022 Sep 2;8(35):eabo7761. doi: 10.1126/sciadv.abo7761.
4
Cryo-electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex.抗利尿激素精氨酸加压素V2受体信号复合物的冷冻电子显微镜结构
Sci Adv. 2021 May 21;7(21). doi: 10.1126/sciadv.abg5628. Print 2021 May.
5
Fluorescent ligands: Bringing light to emerging GPCR paradigms.荧光配体:照亮新兴的G蛋白偶联受体模式。
Br J Pharmacol. 2020 Mar;177(5):978-991. doi: 10.1111/bph.14953. Epub 2020 Feb 6.
6
Covalent Lectin Inhibition and Application in Bacterial Biofilm Imaging.共价凝集素抑制及其在细菌生物膜成像中的应用。
Angew Chem Int Ed Engl. 2017 Dec 22;56(52):16559-16564. doi: 10.1002/anie.201709368. Epub 2017 Nov 28.
7
From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African Trypanosomiasis.从细胞到小鼠再到靶点:用于治疗人类非洲锥虫病的NEU-1053(SB-443342)及其类似物的特性研究
ACS Infect Dis. 2017 Mar 10;3(3):225-236. doi: 10.1021/acsinfecdis.6b00202. Epub 2017 Feb 8.
8
A Broad G Protein-Coupled Receptor Internalization Assay that Combines SNAP-Tag Labeling, Diffusion-Enhanced Resonance Energy Transfer, and a Highly Emissive Terbium Cryptate.一种结合了SNAP标签标记、扩散增强共振能量转移和高发射性铽穴合物的广泛G蛋白偶联受体内化分析方法。
Front Endocrinol (Lausanne). 2015 Nov 9;6:167. doi: 10.3389/fendo.2015.00167. eCollection 2015.
9
Data quality in drug discovery: the role of analytical performance in ligand binding assays.药物研发中的数据质量:分析性能在配体结合测定中的作用。
J Comput Aided Mol Des. 2015 Sep;29(9):847-65. doi: 10.1007/s10822-015-9851-6. Epub 2015 Jun 13.
10
Improved methodical approach for quantitative BRET analysis of G Protein Coupled Receptor dimerization.用于G蛋白偶联受体二聚化定量BRET分析的改进方法学途径。
PLoS One. 2014 Oct 17;9(10):e109503. doi: 10.1371/journal.pone.0109503. eCollection 2014.